These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3083548)

  • 1. Long-term results of cyclosporine treatment in renal transplantation.
    Tilney NL; Milford EL; Carpenter CB; Lazarus JM; Strom TB; Kirkman RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):179-85. PubMed ID: 3083548
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
    Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
    [No Abstract]   [Full Text] [Related]  

  • 5. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y; Waer M; Roels L; Christiaens R; Gruwez J; Michielsen P
    Transplant Proc; 1990 Aug; 22(4):1691-2. PubMed ID: 2389434
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term cyclosporine A treatment does not progressively impair renal graft function: a 5-year follow-up study.
    Linder R; Restifo AC; Lindholm A; Groth CG
    Transplant Proc; 1991 Aug; 23(4):2210. PubMed ID: 1871848
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine in the first month posttransplant.
    Rolles K; Calne RY
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):55-8. PubMed ID: 3515695
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 11. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 12. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients.
    Rocher LL; Landis C; Dafoe DC; Keyserling C; Swartz RD; Campbell DA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2093-5. PubMed ID: 3274476
    [No Abstract]   [Full Text] [Related]  

  • 13. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
    [No Abstract]   [Full Text] [Related]  

  • 17. Fractional excretion of sodium is an early predictor of cyclosporine nephrotoxicity after renal transplantation.
    Morales JM; Andrés A; Hernández E; Prieto C; Ortuño T; Montoyo C; Moreno F; Rodriguez-Paternina E; Farías J; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1728-9. PubMed ID: 2389444
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effects of short-term cyclosporine.
    Chapman JR; Morris PJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):186-91. PubMed ID: 3515686
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of acute tubular necrosis on cyclosporine-treated kidney transplants.
    Paramasivan ON; Griffin PJ; Ross WB; Salaman JR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2085. PubMed ID: 3274474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.